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The efficient production of membrane proteins in bacteria remains a major challenge. In this work, we
sought to identify overexpressed genes that enhance the yields of recombinant membrane proteins in Esche-
richia coli. We developed a genetic selection system for bacterial membrane protein production, consisting of
membrane protein fusions with the enzyme -lactamase and facile selection of high-production strains on
ampicillin-containing media. This system was used to screen the ASKA library, an ordered library of plasmids
encoding all the known E. coli open reading frames (ORFs), and several clones with the ability to accumulate
enhanced amounts of recombinant membrane proteins were selected. Notably, coexpression of ybaB, a gene
encoding a putative DNA-binding protein of unknown function, was found to enhance the accumulation of a
variety of membrane-integrated human G protein-coupled receptors and other integral membrane proteins in
E. coli by up to 10-fold. The results of this study highlight the power of genetic approaches for identifying
factors that impact membrane protein biogenesis and for generating engineered microbial hosts for membrane
protein production.
Between 20 and 30% of the genes of every living organism
are dedicated to the synthesis of membrane proteins (41).
Membrane proteins mediate crucial cellular processes, such as
signal transduction, maintenance of structure, energy produc-
tion, transport of chemicals, etc. (26). From a biotechnological
standpoint, membrane proteins are valuable targets for phar-
maceutical discovery: it is estimated that approximately 50% of
all drugs in use or under development act by modulating the
function of this class of proteins (18). Biochemical, biophysical,
and structural characterizations of membrane proteins could
greatly accelerate the discovery of this type of therapeutics.
Such studies, however, are strongly impeded by the difficulty in
production and isolation of sufficient amounts of protein for
characterization (26, 41).
Apart from a few exceptions, membrane proteins are found
in their native cells and tissues in very low abundance and
therefore cannot be isolated easily in their native state (26, 41).
Their production relies, thus, on recombinant overexpression
in mammalian cell cultures, insect cells, or microbial hosts,
such as yeasts or bacteria (16). Among the available expression
hosts, Escherichia coli has proven very useful for the produc-
tion and biochemical and structural characterization of a num-
ber of membrane proteins (41). However, despite this success,
the production of membrane proteins in simple microbial hosts
remains notoriously problematic, especially for proteins of eu-
karyotic origin (41).
Membrane protein expression in bacteria usually results in
low yields of membrane-integrated and correctly folded
polypeptide; instead, the polypeptide either is degraded or
accumulates in cytoplasmic inclusion bodies, which are difficult
to denature and refold (26). Furthermore, the expression of
membrane proteins has profound effects on cell growth and
physiology (40), further limiting production yields. An example
of the problems associated with membrane protein expression
in bacteria is that, out of more than 100 putative membrane
proteins from Mycobacterium tuberculosis that were studied,
less than 10% could accumulate in the membrane fraction,
while almost 50% did not even yield sufficient protein for
detection by Western blotting (22).
Due to our incomplete understanding of the pathways and
physiological processes that govern membrane protein bio-
genesis, optimization of membrane protein production is
still carried out in an empirical fashion. Optimal conditions
that maximize membrane protein production are usually
identified by testing different basic protein production pa-
rameters, such as expression constructs (vectors, promoters)
and strains, growth media, incubation times, and tempera-
tures, etc. These techniques, however, usually result in lim-
ited success, while they treat the issue of membrane protein
expression as a “black box”.
Recently, protein engineering approaches were deployed to
improve the production of membrane proteins in bacteria. For
example, directed protein evolution was used to isolate mem-
brane protein variants that could be produced in markedly
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enhanced yields (30, 35). However, engineering a protein for
expression can have unintended consequences for its structure
and/or function.
A promising alternative approach for membrane protein
expression is the engineering of the bacterial host itself. In
early studies, Miroux and Walker isolated mutants of E. coli
BL21(DE3) that suppressed the cytotoxicity induced by the
expression of membrane proteins from the strong T7 promoter
(29). Not surprisingly, the reduced cytotoxicity resulted from
mutations that reduced the transcriptional efficiency of the T7
RNA polymerase (42).
In other studies, coexpression of the genes encoding the
chaperone/cochaperone DnaK/DnaJ was shown to result in a
significant increase in the bacterial production of the magne-
sium transporter CorA (3), whereas coexpression of the gene
encoding the membrane-bound protease FtsH resulted in a
dramatic increase in the production of the membrane-incor-
porated and detergent-soluble form of certain human G pro-
tein-coupled receptors (GPCRs) (27). E. coli mutants carrying
chromosomal lesions or transposon insertions that favorably
affect membrane protein accumulation have also been re-
ported (28, 39). These results demonstrate that E. coli can
potentially be engineered to serve as a specialized membrane
protein-producing cell factory, in a fashion similar to what has
been achieved for the production of natural products and small
molecules (7).
In this work, we employed a simple genetic selection system
that links cell growth to the expression of properly folded
heterologous membrane proteins. This system is based on fu-
sions of the N terminus of members of the Nout class of mem-
brane proteins (in which the N terminus is outside the cyto-
plasm) to -lactamase. We used this selection to screen the
ASKA library, a complete library of all individual E. coli genes
expressed from a strong inducible promoter (21), and identi-
fied overexpressed genes that enhance membrane protein pro-
duction. Several such genes were isolated in this manner.
Among these, the gene ybaB, encoding a small protein of
unknown function, was shown to enhance greatly the expres-
sion of multiple membrane proteins, including that of human
GPCRs.
MATERIALS AND METHODS
Strains and plasmids. The E. coli strain MC4100A (MC4100 ara) (34) was
utilized for all experiments. The plasmid pBADBla was generated by ampli-
fication of the gene encoding the mature sequence of TEM-1 -lactamase
(Bla) (lacking its native Sec-dependent signaling sequence) from the vector
pTrc99a (GE Healthcare) with the PCR primers ssDsbABlaSacI (AAAAAA
GAGCTCAGGAGGAAACGATGAAAAAGATTTGGCTGGCGCTGGCT
GGTTTAGTTTTAGCGTTTAGCGCATCGGCGGCGCAGTATGAAGAT
CTGCAGCACCCAGAAACGCTG) and BlaHindIII (GCCTCACTGATTA
AGCATTGGTCTAGATAAGCTGCGAAGCTTAAAAAA). These primers
append to the 5 end of the bla sequence a SacI restriction site, an optimized
Shine-Dalgarno sequence, the signal recognition particle (SRP)-dependent
signaling sequence of DsbA, a PstI restriction site, and, on the 3 end of bla,
a stop codon flanked by the two restriction sites XbaI and HindIII. This PCR
product was digested with SacI and HindIII and ligated into a similarly
digested pBAD-33 vector (17). pBADBla-BR2 was constructed by PCR am-
plification of the human bradykinin receptor 2 (BR2)-encoding gene from
pASKBR2, which contains a codon-optimized BR2 gene for expression in E.
coli (27), and insertion into the XbaI and HindIII sites of pBADBla. pBADBla-
YidC was constructed by PCR amplification of yidC from the E. coli chromosome
and insertion into the XbaI and HindIII sites of pBADBla. pBADBla-YegH was
constructed by PCR amplification of yegH from the E. coli chromosome, diges-
tion with XbaI-SphI, and three-way ligation with the SacI-XbaI-digested bla gene
described above into the SacI and SphI sites of pBAD-33. pBADSmRBla-BR2
was generated by interrupting the chloramphenicol acetyltransferase gene of
pBADBla-BR2 at its MscI site with the aadA (Smr) gene amplified from plasmid
pCDF-1b (Novagen). pBADBR2-GFP, pBADCB1-GFP, pBADNKR1-GFP,
and pBADBR2 were constructed by subcloning BR2-GFP, human central can-
nabinoid receptor 1 (CB1)-GFP, human neurokinin (substance P) receptor 1
(NKR1)-GFP, and BR2 from pASKBR2-GFP, pASKCB1-GFP, pASKNKR1-
GFP, and pASKBR2 (27), respectively, into pBAD30 (17) by utilizing the avail-
able XbaI-HindIII restriction sites. pBADYidC-GFP, pBADCstA-GFP, and
pBADSCD-GFP were constructed by PCR amplification of the membrane pro-
tein-encoding genes and insertion into the XbaI and PstI sites of pBADBR2-
GFP after removal of the BR2-encoding gene.
Conditions of the genetic selection system. For initial testing of the genetic
selection system, 5-l specimens of E. coli MC4100A cells transformed with the
appropriate pBADBla-membrane protein expression vector were spotted onto
Luria-Bertani (LB) agar plates containing 40 g/ml chloramphenicol and 0.1%
L-arabinose, in the absence or presence of different ampicillin concentrations.
For the ASKA library selection, cells were doubly transformed by electropora-
tion with pBADSpRBla-BR2 and the ASKA library, plated onto LB agar plates
containing 50 g/ml spectinomycin, 30 g/ml chloramphenicol, 80 g/ml ampi-
cillin, and 0.1% L-arabinose, either with or without 0.1 mM isopropyl--D-thio-
galactopyranoside (IPTG), and incubated at room temperature for approxi-
mately 2 days.
Protein overexpression and isolation of the total membrane fraction. E. coli
MC4100A cells freshly transformed with the appropriate expression vector were
used for all protein production experiments. Single bacterial colonies were used
to inoculate liquid LB cultures containing the appropriate combination of anti-
biotics (100 g/ml ampicillin, 100 g/ml spectinomycin, or 40 g/ml chloram-
phenicol). These saturated cultures were used with a 1:100 dilution to inoculate
fresh LB cultures containing 0.1 mM IPTG, which were grown at 37°C to an
optical density at 600 nm (OD600) of 0.5 to 0.7 with shaking. The temperature
was then decreased to 25°C, and after a temperature equilibration period of 5 to
20 min, membrane protein expression was induced by the addition of 0.1%
L-arabinose for approximately 5 h (unless otherwise specified). Total membrane
fractions were prepared from cells harvested from 500 ml LB cultures, resus-
pended in 10 ml of cold lysis buffer (10 mM imidazole, 300 mM NaCl, 50 mM
NaH2PO4, 15% glycerol, 5 mM dithiothreitol), and lysed by double passage
through a French press. Cell lysates were then centrifuged twice at 8,000 rpm for
20 min using a Beckman-Coulter JA-10 rotor, and the supernatant was collected
(soluble fraction) and subjected to ultracentrifugation in a Beckman 50 Ti rotor
at 50,000 rpm for 1.5 h at 4°C. Total membranes corresponding to the pellet of
the ultracentrifugation step were resuspended in 10 ml of cold lysis buffer and
homogenized.
Flow cytometry. The fluorescence of cells expressing membrane protein-green
fluorescent protein (GFP) fusions (530/30 nm) was monitored using a Becton-
Dickinson FACSAria flow cytometer and analyzed with FACSDiva software.
Cells were gated based on size on a side-scatter–versus–forward-scatter plot.
Approximately 104 cells were analyzed per sample.
In-gel fluorescence and Western blot analysis. In-gel fluorescence and West-
ern blot analysis were performed as described previously (39).
RESULTS
Development of a genetic selection system for membrane
protein production in E. coli. In order to isolate E. coli variants
with the ability to produce increased amounts of recombinant
membrane proteins rapidly, we utilized fusions of proteins to
-lactamase, a bacterial enzyme which must be exported to the
periplasm in order to confer significant resistance to -lactam
antibiotics, such as ampicillin. We constructed chimeric genes
that encode fusions of the TEM-1 -lactamase (Bla) with the
N termini of different integral membrane proteins exhibiting
various topologies: the E. coli membrane integrase YidC (six
transmembrane helices, Nin-Cin topology [i.e., both the N and
C termini are localized in the cytoplasm]), the E. coli putative
transporter YegH (seven transmembrane helices, Nout-Cin to-
pology), and the human G protein-coupled receptor (GPCR)
bradykinin receptor 2 (BR2) (seven transmembrane helices,
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Nout-Cin topology) (Table 1). Since most native as well as the
majority of the heterologously produced membrane proteins in
E. coli are targeted to the inner membrane via the signal
recognition particle (SRP) pathway (32), we replaced the SRP-
independent signaling sequence of -lactamase (1) with that of
the SRP-dependent exported protein DsbA (ssDsbA) (Fig. 1A,
top; Table 2). ssDsbA-tagged proteins are exported to the
bacterial periplasm through the SRP pathway (37). Bacterial
cells producing membrane proteins with their N termini facing
the periplasm and fused to -lactamase are expected to display
active Bla in the periplasm and grow on ampicillin-containing
media (Bla phenotype). Improper folding of the fusion within
the cytoplasm should not be able to confer antibiotic resistance
(Bla phenotype).
We tested the growth phenotypes of E. coli MC4100A cells
(34) expressing ssDsbA-Bla (SRP-exported Bla; positive con-
trol) or the membrane protein fusions ssDsbA-Bla-YidC,
ssDsbA-Bla-YegH, and ssDsbA-Bla-BR2 on LB agar plates
containing 0.1% L-arabinose to induce protein synthesis from
the araBAD promoter, as well as increasing concentrations of
ampicillin. We observed that only cells expressing Bla fusions
to membrane proteins with Nout topologies could grow on
ampicillin-containing media (Fig. 1B). Expression of the gene
encoding the ssDsbA-Bla fusion with YidC, a protein with a
cytoplasmic N terminus, did not permit bacterial growth even
at ampicillin concentrations as low as 40 g/ml (Fig. 1B).
These results are consistent with previous observations that
Bla is a reliable reporter of membrane protein topology (2).
Expression of the gene encoding exported Bla or the gene for
the Bla fusion with YegH, a well-accumulated bacterial mem-
brane protein (Fig. 1C), resulted in bacterial growth under all
ampicillin concentrations tested, whereas expression of the







YidC E. coli Membrane protein integrase 6 Nin-Cin 61.5
YegH E. coli Putative transporter 7 Nout-Cin 59.5
CstA E. coli Peptide transporter 18 Nin-Cin 75.1
BR2 Homo sapiens Bradykinin receptor 2 (GPCR) 7 Nout-Cin 44.5
CB1 H. sapiens Central cannabinoid receptor (GPCR) 7 Nout-Cin 52.9
NKR1 H. sapiens Neurokinin (substance P) receptor 1 (GPCR) 7 Nout-Cin 46.3
SCD H. sapiens Stearoyl-CoA desaturase 4 Nin-Cin 41.1
FIG. 1. (A) Constructs used in this study. (Top) The pBADBla-MP family of expression vectors includes a membrane protein (MP)-encoding
gene flanked by the SRP-recognized DsbA signaling sequence (ssDsbA) and a C-terminal octahistidine tag under the control of the araBAD
promoter, with an optimized Shine-Dalgarno (SD) sequence. (Bottom) The pBADMP-GFP plasmid family encodes membrane proteins with
C-terminally fused GFP and a tobacco etch virus (TEV) cleavage site between the MP and GFP (no signaling sequence added). (B) Growth
phenotypes of E. coli cells expressing ssDsbA-Bla (Bla) or ssDsbA-Bla-membrane protein fusions (Bla-YidC, Bla-YegH, and Bla-BR2) on LB agar
media containing 0.1% L-arabinose with and without increasing concentrations of ampicillin (Amp; followed by a number indicating an amount
in g/ml). (C) Western blots of isolated total membrane fractions of MC4100A cells expressing ssDsbA-Bla, ssDsbA-Bla-YidC, ssDsbA-Bla-YegH,
or ssDsbA-Bla-BR2, probed with an anti-Bla antibody. Extracts with equal numbers of cells were loaded in the lanes. MM, molecular mass.
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gene encoding the Bla fusion with BR2, a very poorly accumu-
lating human membrane protein (Fig. 1C), allowed bacterial
growth only at low ampicillin concentrations (Fig. 1B). These
results demonstrate that the ssDsbA-Bla fusions can serve as a
reliable reporter for the accumulation of properly localized
membrane proteins.
Selection for single E. coli genes that enhance bacterial
membrane protein production. Having constructed a reliable
and rapid selection system for membrane protein production,
we elected to isolate genes that upon overexpression would
enhance the yields of inner membrane protein production in E.
coli. For this, we utilized the ASKA library, an ordered library
of plasmids encoding all known E. coli open reading frames
(ORFs) under the control of the T5lac promoter (21). As our
model membrane protein, we chose to study the human GPCR
BR2, a membrane protein whose expression in E. coli results in
minute amounts of membrane-embedded polypeptide (Fig.
1C) (27). GPCRs constitute the most important class of drug
targets in pharmaceutical discovery (19), and they are notori-
ously difficult to express, typically yielding very small amounts
of membrane-embedded protein (36).
E. coli MC4100A cells were transformed with the expression
vector pBADSmRBla-BR2 (Table 2) and the ASKA library.
Approximately 106 cells were plated on agar plates containing
0.1% L-arabinose, 50 g/ml spectinomycin, 30 g/ml chloram-
phenicol, and 80 g/ml ampicillin in the presence and absence
of 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG). A
number of Bla colonies appeared on plates both with and
without IPTG after 2 days of growth at room temperature.
Since ampicillin resistance can arise from a number of reasons
not necessarily related to enhanced Bla-BR2 production, such
as altered outer membrane composition or overexpression of a
gene encoding bacterial protein with -lactam hydrolytic ac-
tivity (e.g., the chromosomal ampC gene), it was necessary to
use a secondary screen to further evaluate the phenotypes of
the isolated clones.
Drew et al. have shown that the fluorescence of bacterial
cells expressing GFP fusions to the C termini of Cin membrane
proteins correlates well with the amount of membrane-inte-
grated and properly folded protein expressed (10). ASKA plas-
mids isolated from colonies that grew on ampicillin plates were
transformed into MC4100A cells also containing the vector
pBADBR2-GFP, in which the gene encoding BR2 is fused to
the 3 end of gfpmut2 (5) and expressed under the control of
the araBAD promoter (Fig. 1A, bottom, and Table 2). Cell
fluorescence was analyzed by flow cytometry and compared to
the fluorescence of MC4100A cells overexpressing the gene
encoding BR2-GFP alone. Most of the clones carrying the
plasmids isolated based on ampicillin resistance exhibited re-
producibly higher BR2-GFP fluorescence. Three plasmids
were found to mediate 3-fold or higher BR2-GFP fluorescence
relative to that of controls not containing an ASKA plasmid.
Sequencing led to the identification of the genes ybaB, which
encodes a soluble protein of unknown function, yciQ, which
encodes a putative inner membrane protein also of unknown
function, and glpQ, which encodes the periplasmic glycero-
phosphoryl diester phosphodiesterase enzyme GlpQ (Fig. 2).
Cells overexpressing ybaB exhibited BR2-GFP fluorescence
that was an order of magnitude higher than MC4100A’s (Fig.
2), and therefore this gene was selected for further study.
ybaB coexpression dramatically increases the production of
membrane-bound and properly folded BR2 in E. coli. The level
of accumulation of BR2-GFP in the membrane fractions of
cells coexpressing ybaB was analyzed by Western blotting and
compared to BR2-GFP production in wild-type MC4100A.
While wild-type E. coli cells accumulated miniscule quantities
of membrane-incorporated BR2-GFP, which were barely de-
tectable by Western blotting (Fig. 3A), coexpression of ybaB
resulted in a dramatic increase in the accumulation of the
BR2-GFP fusion (Fig. 3A).
It has recently been shown that correctly folded membrane
protein-GFP fusions retain their fluorescence following so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) of nonboiled protein samples and that the exhibited
in-gel fluorescence is a quantitative measure of the amount of
properly folded membrane protein (14). Protein samples de-
rived from the total membrane fraction of MC4100A cells
overexpressing the gene encoding BR2-GFP without and with
ybaB coexpression were separated by SDS-PAGE and ana-
lyzed for in-gel fluorescence. This analysis showed that ybaB
coexpression results in the production of a highly fluorescent
BR2-GFP band, despite the fact that wild-type bacterial cells
cannot produce any BR2-GFP fluorescence (Fig. 3B). These
results indicate that ybaB coexpression leads to a large en-
hancement of the accumulation of the membrane-integrated
and well-folded BR2 receptor that can be produced in bacteria.
TABLE 2. Plasmids used in this work
Plasmid Protein expresseda Marker Origin ofreplication Source
pBADBla-YidC ssDsbA-Bla-YidC Cmr ACYC This work
pBADBla-YegH ssDsbA-Bla-YegH Cmr ACYC This work
pBADBla-BR2 ssDsbA-Bla-BR2 Cmr ACYC This work
pBADSmRBla-BR2 ssDsbA-Bla-BR2-His8 Sm
r ACYC This work
pBADBR2-GFP FLAG-BR2-TEV-GFP-His8 Amp
r ACYC This work
pBADCB1-GFP FLAG-CB1-TEV-GFP-His8 Amp
r ACYC This work
pBADNKR1-GFP FLAG-NKR1-TEV-GFP-His8 Amp
r ACYC This work
pBADYidC-GFP YidC-TEV-GFP-His8 Amp
r ACYC This work
pBADCstA-GFP FLAG-CstA-TEV-GFP-His8 Amp
r ACYC This work
pBADSCD-GFP FLAG-SCD-TEV-GFP-His8 Amp
r ACYC This work
pBADBR2 FLAG-BR2-His8 Amp
r ACYC This work
ASKA library All known E. coli proteins Cmr ColE1 Kitagawa et al. (21)
a TEV, tobacco etch virus.
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Similar results were also obtained for the other two identi-
fied genes, glpQ and yciQ, although their enhancing effect on
BR2 yield were less pronounced than those observed for ybaB
(Fig. 3A and B and data not shown).
ybaB coexpression resulted in a dramatic enhancement in
the production of membrane-associated receptor also when
BR2 was expressed alone, i.e., without the presence of the GFP
fusion partner (Fig. 3C).
Coexpression of ybaB broadly confers increased production
of prokaryotic and eukaryotic membrane proteins in E. coli.
The effect of ybaB coexpression on the production of five
additional integral membrane proteins of bacterial or human
origin in E. coli was examined. Human central cannabinoid
receptor 1 (CB1), human neurokinin (substance P) receptor 1
(NKR1), the human stearoyl-coenzyme A (CoA) desaturase
(SCD), the E. coli membrane integrase YidC, and the E. coli
putative peptide transporter CstA (Table 1) were produced as
C-terminally fused to GFP (Fig. 1B, bottom; Table 2) in E. coli
MC4100A. Membrane protein production with and without
ybaB coexpression was monitored by flow cytometry. ybaB con-
ferred increased GFP fluorescence to all the membrane pro-
teins tested (Fig. 4). Interestingly, the observed increases in
fluorescence were much more pronounced in the cases of
the GPCRs (900% increase for BR2, 750% for CB1, and
430% for NKR1) than in the membrane proteins not be-
longing to the GPCR superfamily (30% increase for the E.
coli YidC, 70% for E. coli CstA, and 190% for the human
SCD). Thus, ybaB appears to be a general enhancer of
membrane protein production in E. coli, which is particu-
larly effective for GPCRs.
Based on the fluorescence exhibited by CB1-GFP and
BR2-GFP upon coexpression of ybaB and comparison of
this fluorescence with that demonstrated by previous studies
where these receptors were detergent solubilized and puri-
fied by affinity chromatography (27), we estimate that
MC4100A cells overexpressing CB1 and BR2 under the
herein-described conditions can produce 100 g and 1 mg of
detergent-soluble CB1 and BR2 receptor, respectively, per
liter of shake flask culture.
DISCUSSION
In this work, we sought to identify overexpressed genes that
confer enhanced recombinant membrane protein production
FIG. 2. Comparison of the BR2-GFP fluorescence of wild-type
MC4100A cells with the BR2-GFP fluorescence of cells overexpressing
ybaB, yciQ, or glpQ. BR2-GFP was expressed at room temperature for
approximately 5 h. Fluorescence histograms correspond to a popula-
tion of 10,000 cells. M, arithmetic mean; a.u., arbitrary units.
FIG. 3. (A) Comparison of levels of production of membrane-in-
tegrated BR2-GFP fusion in MC4100A cells, with and without coex-
pression of ybaB or glpQ, by Western blotting with anti-GFP antibody.
(B) Comparison of the levels of in-gel fluorescence of the BR2-GFP
fusion in the total lysate and total membrane fraction of MC4100A
cells, with and without coexpression of ybaB or glpQ. (C) Comparison
of the levels of production of the GFP-free BR2 receptor in different
fractions of wild-type MC4100A cells and in MC4100A cells overex-
pressing ybaB by Western blotting with an anti-FLAG antibody. The
total lysate comprises the soluble fraction (which under the conditions
used here includes the membrane fraction) and the insoluble fraction
(comprising cell debris and insoluble protein inclusion bodies [data not
shown]). (A and C) The observed lower-molecular-mass bands likely
correspond to protein degradation products, presumably due to the
low proteolytic stability of BR2-GFP and BR2. Extensive degradation
is typical for membrane-embedded GPCRs in E. coli (27). The full-
length receptor, however, appears to be the major protein product in
both panels. In all panels, BR2 and BR2-GFP were expressed at 25°C
for approximately 5 h. WT, wild type.
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in E. coli. First, we developed a bacterial genetic selection
system for correct membrane protein insertion by utilizing
fusions with the enzyme -lactamase and testing bacterial
growth on ampicillin-containing media. Screening of the
ASKA library led to the identification of three genes whose
coexpression resulted in a marked increase in the production
of the human GPCR BR2: ybaB, glpQ, and yciQ. Among these,
ybaB had the most pronounced effect and was found to have a
broad effect on enhancing membrane protein accumulation,
especially that of human GPCRs.
YbaB is a small, 12-kDa protein whose homologues are
widespread among bacteria (4). The function of YbaB is un-
known. A ybaB homologue appears to be essential for Myco-
bacterium genitalium, a bacterial species with one of the small-
est known genomes (12). However, ybaB does not appear to be
essential in gammaproteobacteria. In a number of bacteria,
including E. coli, Haemophilus influenzae, and Bacillus subtilis,
ybaB is cotranscribed with recR, a gene involved in the recovery
of replication after DNA damage (4). For this reason, YbaB
has been thought to be involved in DNA repair. Recent ob-
servations, however, such as the fact that recR alone is able to
complement the recombination defects of a double ybaB recR
deletion mutant of Streptomyces coelicolor (31), suggest other-
wise (4). The crystal structures of YbaB from E. coli and from
H. influenzae have been solved, revealing a novel protein fold
where a YbaB homodimer forms an -helical tweezers-like
structure (25). This structure appears not to correspond to an
enzyme or to a DNA-binding protein and was proposed to play
a regulatory role by mimicking DNA and competing for bind-
ing to DNA-binding proteins (25). Very recently, however, it
was found that E. coli and H. influenzae YbaBs exhibit specific
DNA binding activity (4).
An important characteristic of ybaB is that it is one of the E.
coli genes whose expression is regulated by the extracytoplas-
mic sigma factor E (33). Apart from being involved in
periplasmic and outer membrane stress responses, E has been
found to be activated in response to the production of mis-
folded inner membrane proteins (38). It is likely that certain
E-regulated genes are involved in the folding/assembly/quality
control pathways of inner membrane proteins in bacteria and
that ybaB may have such a function.
In addition to ybaB, we identified two enhancers of mem-
brane protein expression, yciQ and glpQ. yciQ encodes a puta-
tive inner membrane protein of unknown function with a pre-
dicted Nout-Cin topology and five transmembrane domains
(http://www.cbs.dtu.dk/services/TMHMM-2.0/). It is interest-
ing that the overexpression of such a large inner membrane
protein can assist the production of a second membrane pro-
tein, considering the constraint imposed by the very limited
capacity and the molecular crowding of the bacterial mem-
brane. glpQ encodes the periplasmic glycerophosphoryl diester
phosphodiesterase enzyme GlpQ, which hydrolyzes glycero-
phosphodiesters into an alcohol and sn-glycerol-3-phosphate
(24). sn-Glycerol-3-phosphate can subsequently be transported
into the cytoplasmic space, where it can be utilized for lipid
biosynthesis, such as the synthesis of cardiolipin. Therefore,
one possibility why BR2 production is increased upon glpQ
coexpression is that the membrane lipid composition is altered
in a manner that favors the folding of BR2 and, possibly, of
other mammalian GPCRs as well.
The availability of a genetic selection using Bla fusions can
provide several advantages over the currently available screen-
ing/selection systems that rely on C-terminal fusions to GFP or
cytoplasmic antibiotic resistance markers (8, 10, 27, 28, 39).
Compared to screens with GFP fusions, genetic selections such
as the one reported here allow for a much higher number of
clones to be interrogated, and they do not require expensive
instrumentation, such as a fluorescence-activated cell sorting
(FACS) device for library screening. Furthermore, it has been
observed that cytoplasmic reporter proteins, such as fluores-
cent proteins and enzymes, can sometimes retain their activity
even when they aggregate and form insoluble inclusion bodies
(13). This effect has also been observed when certain cytoplas-
mic reporters are expressed as part of fusions with membrane
proteins (our unpublished results). Thus, a selection system
utilizing a translocated reporter, such as Bla, may be less prone
to false positives than selections/screens that use cytoplasmic
reporter proteins.
The orientations of the N and C termini of integral mem-
brane proteins can be determined experimentally using mem-
brane protein fusions with cytoplasmic or extracytoplasmic re-
porter proteins (9, 11). Furthermore, the number of
transmembrane helices can be predicted with a high degree of
accuracy using bioinformatic tools such as TMHMM (23). By
combining these methods and applying them at a genome-wide
scale, Daley and coworkers have determined the topology of
the entire membrane proteomes of E. coli (6) and the yeast
Saccharomyces cerevisiae (20). These studies indicated that (i)
out the 541 E. coli membrane proteins with more than two
transmembrane helices for which the localization of the C-
terminal tail could be experimentally determined, 146 (27%)
were found to have their N terminus exposed to the periplasm
(6), a topology which is compatible with the use of the -lac-
tamase screen for expression; (ii) out of these 395 inner mem-
brane proteins with cytoplasmically oriented N termini, 71
(13% of the total 541) have their C termini facing the periplas-
mic space; and (iii) the experimentally determined topology of
the yeast membrane proteome (20) as well as the predicted
membrane protein topologies of other genomes based on se-
FIG. 4. Comparison of the levels of fluorescence of different mem-
brane protein-GFP fusions expressed in MC4100A cells without (wild
type) or with overexpression of ybaB (YbaB). The reported values
correspond to the mean values from four replica experiments. Mem-
brane protein-GFP fusions were expressed at room temperature for
approximately 5 h. a.u., arbitrary units.
VOL. 76, 2010 GENETIC SELECTION FOR MEMBRANE PROTEIN EXPRESSION 5857











quence homology (15) has revealed that the distribution of the
extracytoplasmically localized termini of membrane proteins is
very similar to that found in E. coli (6). Thus, a large fraction
of the known or predicted membrane proteins may be com-
patible with the herein-described approach.
We have estimated that the yields of isolated CB1 and BR2
receptors in detergent-solubilized form under the conditions
described here are approximately 100 g and 1 mg per liter of
shake flask culture, respectively. However, for the vast majority
of bacterially expressed mammalian GPCRs, the fraction of
the total protein corresponding to active receptor is typically
very low (36). Since yields of at least 1 mg of isolated protein
per 5 liters of culture in its native functional state are required
for a particular host to become a suitable expression vehicle for
the production of membrane proteins for structural studies
(36), wild-type or engineered E. coli strains are not yet suitable
to serve as expression hosts for most mammalian GPCRs.
Establishing systems with the ability to produce greatly en-
hanced amounts of membrane-integrated receptors, such as
the one described here, however, will assist further studies
focused on increasing the ligand-binding activities of bacteri-
ally produced GPCRs. It must be noted that for eukaryotic
membrane proteins, which are not as problematic as GPCRs
and which can adopt their native conformation and exhibit
activity when produced in E. coli, the yields reported here are
sufficient to provide adequate amounts of protein for biophys-
ical studies.
Bacterial strain engineering appears to be a very promising
approach for generating specialized membrane protein-pro-
ducing E. coli strains. Random or targeted modifications of the
genetic background of the expression host coupled with re-
porter assays or genetic selection systems, such as the one
described here, will likely yield efficient cell hosts for the pro-
duction, isolation, and characterization of membrane proteins
of outstanding pharmacological interest. Importantly, these
approaches can also provide useful and unanticipated insights
into how simple microbial hosts can be optimized for the pro-
duction of complex recombinant proteins.
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